Pricing of HPV vaccines in European tender-based settings-Reference-Cited by-同舟云学术

Pricing of HPV vaccines in European tender-based settings

Published:2018-07-26 Issue:2 Volume:20 Page:271-280
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Qendri Venetia,Bogaards Johannes A.,Berkhof Johannes

Funder

Comparing Health Services Interventions for the Prevention of HPV-Related Cancer project

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-018-0996-9.pdf

Reference51 articles.

1. Chaturvedi, A.K.: Beyond cervical cancer: burden of other HPV-related cancers among men and women. J. Adolesc. Health 46(4), S20–S26 (2010)

2. European Medicines Agency. European public assessment report for Cervarix. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000721/human_med_000694.jsp&mid=WC0b01ac058001d124 . Accessed 15 Nov 2017

3. European Medicines Agency. European public assessment report for Gardasil. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000703/human_med_000805.jsp . Accessed 15 Nov 2017

4. European Medicines Agency. European public assessment report for Gardasil 9. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003852/human_med_001863.jsp&mid=WC0b01ac058001d124 . Accessed 15 Nov 2017

5. US Food and Drug Adminstration. Human Papillomavirus Vaccine. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172678.htm . Accessed 15 Nov 2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the cost-effectiveness of HPV vaccination for adolescent girls in Japan: A comparison of 2-valent, 4-valent, and 9-valent HPV vaccines with consideration of cross-protection;Preventive Medicine;2024-01

2. Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in the Netherlands: a data-driven analysis;2023-12-29

3. Institutions, corruption and transparency in effective healthcare public procurement: Evidence from Central and Eastern Europe;Post-Communist Economies;2023-05-24

4. Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain;Human Vaccines & Immunotherapeutics;2022-11-08

5. Improving consumer welfare in vaccine market: Pricing, government subsidies and consumer awareness;Transportation Research Part E: Logistics and Transportation Review;2022-11